Home | Publications | Healthcare place holder
place holder place holder

Healthcare

Acrux Limited Healthcare - Medical Equipment SWOT Report


Publication Date   May 2008
Publisher   Global Markets Direct
Product Type   Report
Pages   21
ISBN Number   not applicable
Product Code   GMD497
Ask a question about this product?

Price £63.00

approximately: $118 | €80

Summary


Acrux Limited Healthcare - Medical Equipment SWOT Report is a comprehensive report of the company including both quantitative and qualitative research. The report examines the company's business structure and operations, history and products. The report provides strategic insight on the company in the form of a SWOT analysis. This studies the major internal factors which will affect the company's performance e.g. size, strength, cost, revenues and strategy as well as external factors e.g. competitive positioning and industry trends. There is a forward-looking discussion of the opportunities the company can exploit and the threats facing it.

Report Coverage

  • Critical appraisal of the company's positioning using SWOT analysis.
  • Company information, including business descriptions, company history, product lines, key competitors and key employee biographies.
  • Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
  • Key mergers and acquisitions, partnerships, private equity investments and IPOs.

Reasons to buy

  • Support business/sales activities by understanding customers' businesses better.
  • Identify prospective partners and suppliers.
  • Capitalize on your competitors weaknesses and target the market opportunities available to them.

Content


  • 1 Table of Contents
  • 1 Table of Contents
    • 1.1 List of Tables
  • 2 Company Snapshot
    • 2.1 Key Information
    • 2.2 Company Overview
    • 2.3 Financial Performance
  • 3 Business Description
    • 3.1 Business Overview
    • 3.2 Major Products and Services
      • 3.2.1 Overview
  • 4 History
  • 5 SWOT Analysis
    • 5.1 Overview
    • 5.2 Acrux Limited Strengths
      • 5.2.1 Acrux's Platform Technology
      • 5.2.2 Increasing Revenues
      • 5.2.3 Commercialization
    • 5.3 Acrux Limited Weaknesses
      • 5.3.1 Decreasing Cash Flows
      • 5.3.2 Manufacturing Facility
    • 5.4 Acrux Limited Opportunities
      • 5.4.1 Licensing Agreements
      • 5.4.2 FDA Approval of Estradiol MDTS
      • 5.4.3 Growing Contraceptive Market
      • 5.4.4 Product Development
    • 5.5 Acrux Limited Threats
      • 5.5.1 Lengthy Approval Process
      • 5.5.2 Intense Competition
  • 6 Competitors
  • 7 Key Employees
  • 8 Key Employee Biographies
  • 9 Company Statement
  • 10 Locations And Subsidiaries
    • 10.1 Head Office
  • 11 Recent Developments
    • 11.1 Financial Announcements
      • 11.1.1 Feb 25, 2008: Acrux Declares H1 Fiscal 2008 Results
      • 11.1.2 Aug 30, 2007: Acrux Declares Fiscal 2007 Results
      • 11.1.3 Feb 14, 2007: Acrux Declares H1 Fiscal 2007 Results
      • 11.1.4 Aug 31, 2006: Acrux Declares Fiscal 2006 Results
  • 12 Appendix
    • 12.1 Methodology
    • 12.2 About Global Markets Direct
    • 12.3 Contact Us
    • 12.4 Disclaimer
  • List of Tables
    • Table 1: Acrux Limited,Key Facts
    • Table 2: Acrux Limited, SWOT Analysis
    • Table 3: Acrux Limited, Key Employees,